Đang chuẩn bị liên kết để tải về tài liệu:
Screening and surveillance of multiple solid tumours using plasma placental-like chondroitin sulfate A (pl-CSA)

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Placental-like chondroitin sulfate A (pl-CSA) is known to be exclusively synthesized in multiple cancer tissues and associated with disease severity. Here, we aimed to assess whether pl-CSA is released into bio-fluids and can serve as a cancer biomarker. | Screening and surveillance of multiple solid tumours using plasma placental-like chondroitin sulfate A (pl-CSA)

TÀI LIỆU LIÊN QUAN

Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up

Colorectal cancer screening

Lecture Evaluating Screening tests

Virtual screening stategies in drug discovery – A brief overview

A population survey on beliefs around cervical cancer screening: Determining the barriers and facilitators associated with attendance

Ebook In vitro screening of plant resources for extra-nutritional attributes in ruminants: Nuclear and related methodologies

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening

Studies on marker assisted background screening of sorghum downy mildew resistant introgressed lines (BC3F3) in maize

Knowledge, attitude related to cervical cancer screening among women

Development of the Informed Choice in Mammography Screening Questionnaire (IMQ): Factor structure, reliability, and validity